Sarcopenia is a common complication following metabolic and bariatric surgery (MBS) and may adversely affect postoperative outcomes. This review aimed to investigate the effects of structured exercise interventions (SEI) on sarcopenia-related outcomes in patients undergoing bariatric surgery. Randomized and non-randomized trials were included if they used a control group that did not engage in structured exercise, reported at least one relevant outcome, and used SEI either before or after MBS in adults aged over 18 with a BMI ≥ 35 kg/m². Scopus, PubMed, Cochrane Library, Web of Science, and Google Scholar were searched on April 3, 2025. The ROB and ROBINS-I tools were used to evaluate the risk of bias. Quantitative data synthesis was conducted using the random-effects model. The review protocol was registered in the PROSPERO database (ID: CRD420251020805). A total of 4,618 records were screened, of which thirty-three studies (n = 1,545 participants; mean age = 41.3 years; mean BMI = 42.1 kg/m²; 82.2 Structured exercise interventions have improved the maintenance of FFM up to + 1.87 kg. They also improve overall muscle strength, especially through resistance training (SMD = + 0.74). Functional and aerobic capacities improve significantly with these interventions (SMD = + 0.60). Combined training started early and maintained for ≥ 6 months improves sarcopenia-related outcomes.
Dementia is a progressive neurodegenerative disorder and a leading cause of disability worldwide, with Alzheimer’s disease (AD), vascular dementia (VaD), and Lewy body dementias (LBD) representing the most common subtypes. Its rising prevalence, driven by population aging, underscores the urgent need for accessible biomarkers to support early risk identification and prevention. Insulin resistance (IR) has emerged as a key metabolic mechanism involved in cognitive decline and neurodegeneration. The triglyceride–glucose (TyG) index, derived from routine fasting glucose and triglyceride levels, is a simple and cost-effective surrogate marker of IR. Evidence suggests that higher TyG values are associated with an increased risk of dementia, adverse neuroimaging and biomarker profiles, and cerebrovascular and neurodegenerative changes, although findings remain heterogeneous. This review summarizes the current evidence linking the TyG index to major dementia subtypes and discusses the underlying pathophysiological mechanisms and clinical implications. A graphical abstract illustrating the proposed metabolic–neurodegenerative pathways is also provided.
Sleep is critical for early development, yet sleep disturbances are prevalent. In low- and middle-income countries (LMICs) like Iran, cultural practices can significantly shape sleep behaviors. This study aimed to identify behavioral and parental factors associated with sleep quality among infants and toddlers aged 0–36 months in Iran. This cross-sectional study surveyed 358 parents using the validated Persian version of the Brief Infant Sleep Questionnaire-Revised (BISQ-R). Multiple linear regression was conducted to examine associations between behavioral and parental factors and the BISQ-R Total Sleep Score. The mean Total Sleep Score was 64.2 (SD = 14.3), indicating moderate overall sleep quality. The final regression model explained 28
Introduction Neurological manifestations are rare in hyperlipidemia; however, extreme hypertriglyceridemia may cause "milky" blood and cerebrospinal fluid (CSF) and may compromise the central nervous system. We report an infant with familial hyperlipidemia who presented with seizures and unusual neuroimaging findings, including fat deposition in the cerebral vasculature and intracranial xanthomas. Case description A 2-month-old boy, previously healthy, presented with fever, followed by a focal seizure. His parents are consanguineous. His perinatal history and early development are unremarkable. Physical examination revealed no abnormal findings. During phlebotomy, the blood appeared lipemic with a distinctive 'salmon-colored' hue. Laboratory work-up revealed severe hypertriglyceridemia with normal pancreatic enzymes; other metabolic, hematologic, and infectious evaluations were unremarkable. Non-contrast brain CT and MRI showed fat within the dural venous sinuses and cortical veins, along with two extra-axial, fat-containing intracranial lesions in the left parietal and right frontal regions. The patient was treated with anticonvulsant medications, antiplatelet therapy, and a specialized low-fat formula, resulting in significant improvement in lipid levels and clinical stabilization. Discussion In severe hypertriglyceridemia causing visible lipemia of blood, blood viscosity increases and perfusion in the microcirculation can be impaired. Hyperviscosity and the toxic effect of lipid particles on the endothelium may lead to vascular injury in the brain. Accumulation of lipid in intracranial blood vessels can extravasate through the injured blood-brain barrier to CSF and brain parenchyma. Intracranial xanthoma, parenchymal hemorrhage and infarction are considered as the complications. Conclusions In infants presenting with seizures or stroke-like signs alongside lipemic blood, clinicians should consider hyperlipidemia-induced neurovascular injury. Neuroimaging signs such as fat-density vessels or lesions should prompt an evaluation for dyslipidemia.